United States · FDA National Drug Code directory
Dapsone 100 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83098-101_2127568d-553c-c142-e063-6394a90a4ef7
- Product NDC
- 83098-101
- Form
- TABLET
- Composition / generic term
- Dapsone Tablets
- Labeler
- Everest Life Sciences. LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240901
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPSONE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (83098-101-01) · 83098-101-01
- 30 TABLET in 1 BOTTLE (83098-101-03) · 83098-101-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →